These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26361367)

  • 21. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
    Nadkarni AS; Schliep T; Khan L; Zeana CB
    Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
    Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC
    J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
    He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
    PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
    Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods.
    Bulik CC; Fauntleroy KA; Jenkins SG; Abuali M; LaBombardi VJ; Nicolau DP; Kuti JL
    J Clin Microbiol; 2010 Jul; 48(7):2402-6. PubMed ID: 20484603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae.
    Gaspar GG; Bellissimo-Rodrigues F; Andrade LN; Darini AL; Martinez R
    Rev Soc Bras Med Trop; 2015; 48(4):483-7. PubMed ID: 26132495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
    Lee M; Chung HS
    J Microbiol Methods; 2015 May; 112():87-91. PubMed ID: 25794901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
    Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
    Antochevis LC; Magagnin CM; Nunes AG; Goulart TM; Martins AS; Cayô R; Gales AC; Barth AL; Zavascki AP
    J Glob Antimicrob Resist; 2018 Dec; 15():173-177. PubMed ID: 30071353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
    Hagihara M; Crandon JL; Urban C; Nicolau DP
    J Antimicrob Chemother; 2013 Jul; 68(7):1616-8. PubMed ID: 23475648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel.
    Chmelnitsky I; Hermesh O; Navon-Venezia S; Strahilevitz J; Carmeli Y
    J Antimicrob Chemother; 2009 Oct; 64(4):718-22. PubMed ID: 19656782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.
    Bergamasco MD; Barroso Barbosa M; de Oliveira Garcia D; Cipullo R; Moreira JC; Baia C; Barbosa V; Abboud CS
    Transpl Infect Dis; 2012 Apr; 14(2):198-205. PubMed ID: 22093103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China.
    Qi Y; Wei Z; Ji S; Du X; Shen P; Yu Y
    J Antimicrob Chemother; 2011 Feb; 66(2):307-12. PubMed ID: 21131324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.
    Mezzatesta ML; Gona F; Caio C; Petrolito V; Sciortino D; Sciacca A; Santangelo C; Stefani S
    Clin Microbiol Infect; 2011 Sep; 17(9):1444-7. PubMed ID: 21668577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 3 Etest(®) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species.
    Pankey GA; Ashcraft DS; Dornelles A
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):220-6. PubMed ID: 23993213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
    Cojutti P; Sartor A; Bassetti M; Scarparo C; Pea F
    J Glob Antimicrob Resist; 2018 Sep; 14():238-241. PubMed ID: 29775786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC beta-lactamase-producing Klebsiella pneumoniae.
    Lee SY; Park YJ; Oh EJ; Yoo JK; Park JJ; Park KG; Han K
    Clin Microbiol Infect; 2007 May; 13(5):539-41. PubMed ID: 17331122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.